Brad Hively - Nov 12, 2021 Form 4/A - Amendment Insider Report for Oncology Institute, Inc. (TOI)

Role: Chief Executive Officer, Director
Signature: By: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively
Stock symbol: TOI
Transactions as of: Nov 12, 2021
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 11/18/2021, 07:25 PM
Date Of Original Report: Nov 16, 2021
Next filing: Mar 29, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TOI	Common Stock	Award	$0	+141K		$0.00	141K	Nov 12, 2021	Direct	F1, F2
transaction	TOI	Common Stock	Award	$0	+212K	+140.09%	$0.00	363K	Nov 12, 2021	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On November 12, 2021, pursuant to that certain Agreement and Plan of Merger ("Merger Agreement"), dated as June 28, 2021, by and among DFP Healthcare Acquisitions Corp. ("DFP"), Orion Merger Sub I, Inc. ("First Merger Sub"), Orion Merger Sub II, LLC ("Second Merger Sub"), and TOI Parent, Inc. ("Old TOI"), First Merger Sub merged into Old TOI, with Old TOI being the surviving corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the "Business Combination"). Upon consummation of the Business Combination, each issued and outstanding share of common stock of Old TOI was automatically cancelled and the holder thereof was entitled to receive its allocable share of cash and stock consideration pursuant to the Merger Agreement.
F2	These shares were received in connection with the Business Combination and represent restricted earn-out shares subject to forfeiture and unvested until such time the Issuer's stock price reaches $12.50 per share for 20 days within any 30 consecutive trading days for the two-year period following the closing of the Business Combination, subject to continued employment at such time.
F3	The shares were received in connection with the Business Combination and represent restricted earn-out shares subject to forfeiture and unvested until such time the Issuer's stock price reaches $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following the closing of the Business Combination, subject to continued employment at such time.

Remarks:

This amendment is filed in order to correct the transaction date and the total holdings. Only the corrected transaction lines are restated in this amendment.